Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options
Enterobacteriaceae are spread worldwide and the diseases they cause may be fatal especially in immunocompromised patients. Moreover, the high prevalence of ESBL producing Salmonella and Shigella species diseases worldwide suggests major underlying safety issues. According to the World Health Organiz...
Saved in:
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Media SA
2021
|
| Subjects: | |
| Online Access: | 23996 |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1869514735858221056 |
|---|---|
| author | Ghassan M. Matar |
| author_browse | Ghassan M. Matar |
| author_facet | Ghassan M. Matar |
| author_sort | Ghassan M. Matar |
| collection | Directory of Open Access Books |
| description | Enterobacteriaceae are spread worldwide and the diseases they cause may be fatal especially in immunocompromised patients. Moreover, the high prevalence of ESBL producing Salmonella and Shigella species diseases worldwide suggests major underlying safety issues. According to the World Health Organization (WHO), 2015, approximately 220 million children contract diarrhoeal diseases every year and 96 000 die. As a result, the increase in single or multi drug-resistant foodborne bacterial pathogens is of major public health concern. Moreover, resistance to antimicrobials was found among Salmonella spp and Campylobacter spp from animals and food, and since fluoroquinolones became licensed for use in animal foods, especially for poultry, the rate of fluoroquinolone resistant Salmonella spp and Campylobacter spp in animals and human food, and then in human infections, rapidly increased. To that purpose, the findings of the conducted studies in the book chapters, 1) highlight surveillance studies reporting the occurrence and distribution of resistance to antimicrobial agents, namely, to third generation cephalosporins, carbapenems and fluoroquinolones, 2) describe the mechanisms of transmission of resistance determinants from animals, food products and clinical specimens, that allow implementation of appropriate measures to control their spread and adopt appropriate therapeutic measures, and 3) provide treatment options, useful to medical practice. |
| format | Online |
| id | doab-20.500.12854ir-46251 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Frontiers Media SA |
| publisherStr | Frontiers Media SA |
| record_format | ojs |
| spelling | doab-20.500.12854ir-462512024-04-05T17:30:59Z Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options Ghassan M. Matar QR1-502 Q1-390 Resistance Treatment ESBLs surveillance carbapenemases Enterobacteriaceae thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) Enterobacteriaceae are spread worldwide and the diseases they cause may be fatal especially in immunocompromised patients. Moreover, the high prevalence of ESBL producing Salmonella and Shigella species diseases worldwide suggests major underlying safety issues. According to the World Health Organization (WHO), 2015, approximately 220 million children contract diarrhoeal diseases every year and 96 000 die. As a result, the increase in single or multi drug-resistant foodborne bacterial pathogens is of major public health concern. Moreover, resistance to antimicrobials was found among Salmonella spp and Campylobacter spp from animals and food, and since fluoroquinolones became licensed for use in animal foods, especially for poultry, the rate of fluoroquinolone resistant Salmonella spp and Campylobacter spp in animals and human food, and then in human infections, rapidly increased. To that purpose, the findings of the conducted studies in the book chapters, 1) highlight surveillance studies reporting the occurrence and distribution of resistance to antimicrobial agents, namely, to third generation cephalosporins, carbapenems and fluoroquinolones, 2) describe the mechanisms of transmission of resistance determinants from animals, food products and clinical specimens, that allow implementation of appropriate measures to control their spread and adopt appropriate therapeutic measures, and 3) provide treatment options, useful to medical practice. 2021-02-11T12:25:52Z 2021-02-11T12:25:52Z 2017-10-13 14:57:01 2017 book 23996 16648714 9782889451890 https://directory.doabooks.org/handle/20.500.12854/46251 eng Frontiers Research Topics image/jpeg Attribution 4.0 International http://www.frontiersin.org/books/Emerging_Enterobacteriaceae_Infections_Antibiotic_Resistance_and_Novel_Treatment_Options/1219 http://journal.frontiersin.org/researchtopic/2121/emerging-enterobacteriaceae-infections-antibiotic-resistance-and-novel-treatment-options Frontiers Media SA 10.3389/978-2-88945-189-0 10.3389/978-2-88945-189-0 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889451890 115 open access |
| spellingShingle | QR1-502 Q1-390 Resistance Treatment ESBLs surveillance carbapenemases Enterobacteriaceae thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) Ghassan M. Matar Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options |
| title | Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options |
| title_full | Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options |
| title_fullStr | Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options |
| title_full_unstemmed | Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options |
| title_short | Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options |
| title_sort | emerging enterobacteriaceae infections antibiotic resistance and novel treatment options |
| topic | QR1-502 Q1-390 Resistance Treatment ESBLs surveillance carbapenemases Enterobacteriaceae thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) |
| topic_facet | QR1-502 Q1-390 Resistance Treatment ESBLs surveillance carbapenemases Enterobacteriaceae thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) |
| url | 23996 |
| work_keys_str_mv | AT ghassanmmatar emergingenterobacteriaceaeinfectionsantibioticresistanceandnoveltreatmentoptions |